PT  - JOURNAL ARTICLE
AU  - bhardwaj, Pankaj
AU  - Godatwar, Pawan Kumar
AU  - Charan, Jaykaran
AU  - Sharma, Sanjeev
AU  - Shafi, Shazia
AU  - Chauhan, Nishant
AU  - Vyas, Pratibha
AU  - Dutt, Naveen
AU  - Midha, Naresh
AU  - Jalandra, Ramniwas
AU  - Sharma, Meenakshi
AU  - Nag, Vijaya Lakshmi
AU  - Sharma, Suman
AU  - Singh, Sarvesh Kumar
AU  - Sharma, Praveen
AU  - Misra, Sanjeev
TI  - Efficacy and Safety of Ayurveda Intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections – An open labelled, Parallel Group, Randomized controlled clinical trial
AID  - 10.1101/2021.08.10.21261836
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.08.10.21261836
4099  - http://medrxiv.org/content/early/2021/09/27/2021.08.10.21261836.short
4100  - http://medrxiv.org/content/early/2021/09/27/2021.08.10.21261836.full
AB  - The authors have withdrawn this manuscript because they found a serious issue in data-analysis which leads to wrong interpretation of the results. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCTRI/2020/06/026002Funding StatementThis study was funded by National Institute of Ayurveda. (An autonomous body under the ministry of AYUSH), Madhav Vilas Palace, Jorawar Singh Gate, Amer Road, Jaipur-302002 (Rajasthan), India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Human Ethics Committee of All India Institute of Medical Sciences, JodhpurAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available with Principal Investigator - Dr. Pankaj Bhardwaj